Michele Walsh

Senior Director Regulatory Affairs at Larimar Therapeutics

Michele Walsh, RAC has a long history of experience in Regulatory Affairs. Michele began their career in 1990 at Wyeth, where they worked as a Senior Coordinator and Clinical Data Manager. In 2001, they moved to Cephalon, where they worked as a Manager of Regulatory Affairs. In 2004, they began working at Duramed Research as an Associate Director/Director of Regulatory Affairs. In 2009, they moved to Teva Pharmaceuticals, where they worked as a Director of Regulatory Affairs in the Women's Health Department. In 2012, they began working at CSL Behring, where they worked as a Global Regulatory Lead and US Regional Regulatory in Cardiovascular, Immunology, Thrombosis, Respiratory departments. In 2019, they moved to Aclaris Therapeutics, Inc. as a Director of Regulatory Affairs, and in 2020 they began working at Larimar Therapeutics Inc. as a Senior Director and Director of Regulatory Affairs.

Michele Walsh attended Cardinal O'Hara High School in Springfield, PA. Michele then received their RAC - US certification from Regulatory Affairs Professionals Society (RAPS). Finally, they earned their BA in Biology from Rosemont College.

Location

Philadelphia, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Larimar Therapeutics

Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease.


Industries

Employees

11-50

Links